CyPPA
CAS No. 73029-73-9
CyPPA( —— )
Catalog No. M24739 CAS No. 73029-73-9
CyPPA, a subtype-selective positive modulator of SK channels, decreased spontaneous firing rate, increased the duration of the apamin-sensitive afterhyperpolarization.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 61 | In Stock |
|
| 2MG | 35 | In Stock |
|
| 5MG | 56 | In Stock |
|
| 10MG | 80 | In Stock |
|
| 25MG | 169 | In Stock |
|
| 50MG | 275 | In Stock |
|
| 100MG | 456 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1004 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCyPPA
-
NoteResearch use only, not for human use.
-
Brief DescriptionCyPPA, a subtype-selective positive modulator of SK channels, decreased spontaneous firing rate, increased the duration of the apamin-sensitive afterhyperpolarization.
-
DescriptionCyPPA, a subtype-selective positive modulator of SK channels, decreased spontaneous firing rate, increased the duration of the apamin-sensitive afterhyperpolarization.
-
In VitroCyPPA induces a concentration-dependent increase in the apparent Ca2+-sensitivity of channel activation, changing the EC50 (Ca2+) from 429 nM to 59 nM.
-
In VivoCyPPA, a positive modulator of small-conductance Ca2+-activated K+ channels, inhibits phasic uterine contractions and delays preterm birth in mice.
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorDopamine| SK3| SK2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number73029-73-9
-
Formula Weight285.39
-
Molecular FormulaC16H23N5
-
Purity>98% (HPLC)
-
SolubilityDMSO : 99 mg/mL (346.89 mM; Need ultrasonic)
-
SMILESCc1cc(C)nn1-c1nc(NC2CCCCC2)cc(C)n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
ONC206
ONC206 is an analogue of TRAIL inducer ONC201 and is a selective antagonist of the D2-like dopamine receptors (DRD2/3/4) at nanomolar concentrations. ONC206 also has broad-spectrum anti-tumor activity. ONC206 (Oncoceutics) is an imipiridone with nanomolar potency and analogue of ONC201, a selective dopamine receptor D2 (DRD2) antagonist currently being investigated in phase II clinical trials for serous endometrial cancer (SEC).??
-
Tetrabenazine
Tetrabenazine is a VMAT-inhibitor used for treatment of hyperkinetic movement disorder.
-
Zotepine
Zotepine, an antipsychotic agent, is a potent antagonist of 5-HT2A, 5-HT2C, Histamine H1, α1-adrenergic, and Dopamine D2 receptors, with Kds of 2.6 nM, 3.2 nM, 3.3 nM, 7.3 nM, and 8 nM, respectively.
Cart
sales@molnova.com